Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients

Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients

The severity, disabilities, and lethality caused by the coronavirus 2019 (COVID-19) disease have dumbfounded the entire world on an unprecedented scale. The multifactorial aspect of the infection has generated interest in understanding the clinical history of COVID-19, particularly the classificatio...

Full description

Bibliographic Details
Main Authors: Lucas Barbosa Oliveira, Victor Irungu Mwangi, Marco Aurélio Sartim, Jeany Delafiori, Geovana Manzan Sales, Arthur Noin de Oliveira, Estela Natacha Brandt Busanello, Fernando Fonseca de Almeida e Val, Mariana Simão Xavier, Fabio Trindade Costa, Djane Clarys Baía-da-Silva, Vanderson de Souza Sampaio, Marcus Vinicius Guimarães de Lacerda, Wuelton Marcelo Monteiro, Rodrigo Ramos Catharino, Gisely Cardoso de Melo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Microbiology
Subjects:
metabolomics
mass spectrometry
COVID-19
SARS-CoV-2
metabolites
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.844283/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2022.844283/full

Similar Items